These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28516282)

  • 21. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
    Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
    Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.
    Costa-Mallen P; Gatenby C; Friend S; Maravilla KR; Hu SC; Cain KC; Agarwal P; Anzai Y
    J Neurol Sci; 2017 Jul; 378():38-44. PubMed ID: 28566175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
    Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
    Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
    Shin C; Lee S; Lee JY; Rhim JH; Park SW
    J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.
    Huddleston DE; Langley J; Sedlacik J; Boelmans K; Factor SA; Hu XP
    Hum Brain Mapp; 2017 May; 38(5):2627-2634. PubMed ID: 28240402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
    Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease.
    Prasad S; Stezin A; Lenka A; George L; Saini J; Yadav R; Pal PK
    Eur J Neurol; 2018 Apr; 25(4):680-686. PubMed ID: 29341412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different iron deposition patterns in akinetic/rigid-dominant and tremor-dominant Parkinson's disease.
    Xiong W; Li LF; Huang L; Liu Y; Xia ZC; Zhou XX; Tang BS; Guo JF; Lei LF
    Clin Neurol Neurosurg; 2020 Nov; 198():106181. PubMed ID: 33022525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.
    Jin L; Wang J; Jin H; Fei G; Zhang Y; Chen W; Zhao L; Zhao N; Sun X; Zeng M; Zhong C
    Eur J Neurol; 2012 Jul; 19(7):969-76. PubMed ID: 22288465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease.
    Xiao B; He N; Wang Q; Cheng Z; Jiao Y; Haacke EM; Yan F; Shi F
    Neuroimage Clin; 2019; 24():102070. PubMed ID: 31734535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.
    Ulla M; Bonny JM; Ouchchane L; Rieu I; Claise B; Durif F
    PLoS One; 2013; 8(3):e57904. PubMed ID: 23469252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.
    Kim TH; Lee JH
    PLoS One; 2014; 9(11):e112512. PubMed ID: 25386854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular, flow and perfusion abnormalities in Parkinson's disease.
    Zhang C; Wu B; Wang X; Chen C; Zhao R; Lu H; Zhu H; Xue B; Liang H; Sethi SK; Haacke EM; Zhu J; Peng Y; Cheng J
    Parkinsonism Relat Disord; 2020 Apr; 73():8-13. PubMed ID: 32182553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson's Disease on Brain Networks.
    Wen J; Guo T; Wu J; Bai X; Zhou C; Wu H; Liu X; Chen J; Cao Z; Gu L; Pu J; Zhang B; Zhang M; Guan X; Xu X
    J Parkinsons Dis; 2022; 12(8):2479-2492. PubMed ID: 36336939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease.
    Zang Z; Song T; Li J; Yan S; Nie B; Mei S; Ma J; Yang Y; Shan B; Zhang Y; Lu J
    Hum Brain Mapp; 2022 Aug; 43(12):3735-3744. PubMed ID: 35471638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease.
    Wang J; Huang Z; Li Y; Ye F; Wang C; Zhang Y; Cheng X; Fei G; Liu K; Zeng M; Zhong C; Jin L
    Parkinsonism Relat Disord; 2019 Jan; 58():3-8. PubMed ID: 30037690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Imaging in Parkinson's Disease: New Developments.
    Prange S; Metereau E; Thobois S
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):50. PubMed ID: 31214847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.